k.kuusela

TL2 Moderator · Coimbra

Contributes reviews on supplier material. Based in Coimbra.

Joined 27 September 2025 · last posted 6d

74Posts here

2Topics

0Solutions

368Likes received

304Likes given

22Badges

165Days visited

1.9kPosts read

Recent activity

Full stream

Prior authorisation: what the criteria usually require — a second dataset Replied, post #56 · Access › Insurance & coverage · 22 Jul 2026 · 7 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #39 · Practice › Interactions · 18 Jul 2026 · 3 likes Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows gastric emptying), the delayed stomach emptying affects when and…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #47 · Analytics › HPLC & UHPLC · 18 Jul 2026 · 0 likes Coming back to post #45, because the follow-up matters more than the original answer. System suitability testing: injections run before and during the sample run to…
What I would want from a home test that does not exist yet — what changed since Replied, post #96 · Analytics › Home & field testing · 16 Jul 2026 · 15 likes What you can use home tests for: confirmation that a solution contains peptide (as opposed to being saline alone), rough screening for very different compounds…
Primary endpoint hierarchies and why order matters — one year on Replied, post #43 · Evidence › Trials · 11 Jul 2026 · 0 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #30 · Compounds › Retatrutide · 11 Jul 2026 · 20 likes Hepatic effects: glucagon receptor agonism promotes hepatic fat oxidation, which is mechanistically plausible for benefit in metabolic liver disease. Whether that…
What a certificate commits its issuer to Replied, post #12 · Analytics › COA interpretation · 11 Jul 2026 · 11 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
A site rotation scheme that is easy enough to actually follow — a second dataset Replied, post #5 · Practice › Administration · 8 Jul 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. A genuinely late dose: the labelling generally says that if the next dose is more than a couple…
The report format the maintainers ask for, and why each field is there Replied, post #2 · Sourcing › Vendor reports · 24 Jun 2026 · 0 likes I read the opening post twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want…
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #83 · Evidence › Preprints · 19 Jun 2026 · 0 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #4 · Compounds › Retatrutide · 18 Jun 2026 · 1 like Worth separating two things that post #3 runs together. Glucagon receptor agonism seems paradoxical in a weight-loss compound because glucagon raises blood glucose. The…
Does dual agonism explain the effect size, or is it dose? Replied, post #21 · Compounds › Tirzepatide · 7 Jun 2026 · 6 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…